Magellan Minutes Series 4 - Novartis, US political risks and investing in cancer research innovations

John Wylie, Portfolio Manager/Head of Healthcare

Join John Wylie, Portfolio Manager and Head of Healthcare, as he reviews how Novartis is positioned, provides an overview of the US political risks to the healthcare sector, and addresses how innovation in the prevention of cancer may translate to potential investment profits

powered by